Home

večnim Glad uložak median overall survival non hodgkins lymphoma bend motiv Uvek

Burkitt lymphoma in the modern era: real-world outcomes and prognostication  across 30 US cancer centers - ScienceDirect
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers - ScienceDirect

Five-year overall and progression-free survival rates of Hodgkin... |  Download Scientific Diagram
Five-year overall and progression-free survival rates of Hodgkin... | Download Scientific Diagram

Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in  Real-World Settings: Findings From the Hemato-Oncology Latin America  Observational Registry Study | JCO Global Oncology
Clinical Outcomes of Patients With B-Cell Non-Hodgkin Lymphoma in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study | JCO Global Oncology

Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's  Lymphoma | NEJM
Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin's Lymphoma | NEJM

Survival after progression in patients with follicular lymphoma: analysis  of prognostic factors - ScienceDirect
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors - ScienceDirect

Overall survival for different subtypes of non-Hodgkin lymphoma | Download  Scientific Diagram
Overall survival for different subtypes of non-Hodgkin lymphoma | Download Scientific Diagram

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas  | NEJM
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM

Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... |  Download Scientific Diagram
Overall Survival of 3,315 Non-Hodgkin's Lymphoma (NHL) Patients... | Download Scientific Diagram

Improving survival of 3760 patients with lymphoma: Experience of an  academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley  Online Library
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades - Liu - 2020 - Cancer Medicine - Wiley Online Library

Non-Hodgkin Lymphoma (NHL) | Treatment Challenges
Non-Hodgkin Lymphoma (NHL) | Treatment Challenges

Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A  retrospective multicentric cohort study - eClinicalMedicine
Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study - eClinicalMedicine

Patterns of change in treatment, response, and outcome in patients with  follicular lymphoma over the last four decades: a single-center experience  | Blood Cancer Journal
Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience | Blood Cancer Journal

Non-Hodgkin lymphoma - The Lancet
Non-Hodgkin lymphoma - The Lancet

The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas  | NEJM
The Natural History of Initially Untreated Low-Grade Non-Hodgkin's Lymphomas | NEJM

Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell  Lymphoma, 1995–2016: A SEER-Based Analysis
Frontiers | Survival Trends in Patients Under Age 65 Years With Mantle Cell Lymphoma, 1995–2016: A SEER-Based Analysis

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large  B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated  in the Rituximab Era | Scientific Reports
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports

prognosis of non Hodgkin's lymphoma - Primary Care Notebook
prognosis of non Hodgkin's lymphoma - Primary Care Notebook

Median Survival Time - an overview | ScienceDirect Topics
Median Survival Time - an overview | ScienceDirect Topics

Follicular lymphoma in the modern era: survival, treatment outcomes, and  identification of high-risk subgroups | Blood Cancer Journal
Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups | Blood Cancer Journal

Surgery for Primary Central Nervous System Lymphoma: Is It Time for  Reevaluation?
Surgery for Primary Central Nervous System Lymphoma: Is It Time for Reevaluation?

Cureus | Primary Thyroid Lymphoma: An Analysis of the National Cancer  Database
Cureus | Primary Thyroid Lymphoma: An Analysis of the National Cancer Database

Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural  Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative  Group
Frontiers | Treatment, Survival, and Prognosis of Advanced-Stage Natural Killer/T-Cell Lymphoma: An Analysis From the China Lymphoma Collaborative Group

Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin  lymphoma - Ehrhardt - 2019 - British Journal of Haematology - Wiley Online  Library
Long‐term survivors of childhood, adolescent and young adult non‐Hodgkin lymphoma - Ehrhardt - 2019 - British Journal of Haematology - Wiley Online Library

Age-standardized incidence and mortality rates of Hodgkin's lymphoma... |  Download Scientific Diagram
Age-standardized incidence and mortality rates of Hodgkin's lymphoma... | Download Scientific Diagram

Non-Hodgkin's Lymphoma in the Elderly (Part 1: Overview and Treatment of  Follicular Lymphoma)
Non-Hodgkin's Lymphoma in the Elderly (Part 1: Overview and Treatment of Follicular Lymphoma)

Predictive value of serological factors, maximal standardized uptake value  and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma
Predictive value of serological factors, maximal standardized uptake value and ratio of Ki67 in patients diagnosed with non‑Hodgkin's lymphoma

Diagnostics | Free Full-Text | Imaging of Early Response to Predict  Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma  with Iodine-131-Rituximab Radioimmunotherapy
Diagnostics | Free Full-Text | Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy